These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 16373583)
1. C-phycocyanin protects against ischemia-reperfusion injury of heart through involvement of p38 MAPK and ERK signaling. Khan M; Varadharaj S; Ganesan LP; Shobha JC; Naidu MU; Parinandi NL; Tridandapani S; Kutala VK; Kuppusamy P Am J Physiol Heart Circ Physiol; 2006 May; 290(5):H2136-45. PubMed ID: 16373583 [TBL] [Abstract][Full Text] [Related]
2. Attenuation of myocardial ischemia-reperfusion injury by trimetazidine derivatives functionalized with antioxidant properties. Kutala VK; Khan M; Mandal R; Ganesan LP; Tridandapani S; Kalai T; Hideg K; Kuppusamy P J Pharmacol Exp Ther; 2006 Jun; 317(3):921-8. PubMed ID: 16467453 [TBL] [Abstract][Full Text] [Related]
3. Cardioprotection by polysaccharide sulfate against ischemia/reperfusion injury in isolated rat hearts. Yang Y; Hu SJ; Li L; Chen GP Acta Pharmacol Sin; 2009 Jan; 30(1):54-60. PubMed ID: 19098935 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK. Moolman JA; Hartley S; Van Wyk J; Marais E; Lochner A Cardiovasc Drugs Ther; 2006 Feb; 20(1):13-25. PubMed ID: 16552474 [TBL] [Abstract][Full Text] [Related]
5. Ferulic Acid Administered at Various Time Points Protects against Cerebral Infarction by Activating p38 MAPK/p90RSK/CREB/Bcl-2 Anti-Apoptotic Signaling in the Subacute Phase of Cerebral Ischemia-Reperfusion Injury in Rats. Cheng CY; Tang NY; Kao ST; Hsieh CL PLoS One; 2016; 11(5):e0155748. PubMed ID: 27187745 [TBL] [Abstract][Full Text] [Related]
6. Activation of p38 mitogen-activated protein kinase abolishes insulin-mediated myocardial protection against ischemia-reperfusion injury. Chai W; Wu Y; Li G; Cao W; Yang Z; Liu Z Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E183-9. PubMed ID: 18003719 [TBL] [Abstract][Full Text] [Related]
7. Glucosamine cardioprotection in perfused rat hearts associated with increased O-linked N-acetylglucosamine protein modification and altered p38 activation. Fülöp N; Zhang Z; Marchase RB; Chatham JC Am J Physiol Heart Circ Physiol; 2007 May; 292(5):H2227-36. PubMed ID: 17208994 [TBL] [Abstract][Full Text] [Related]
8. Ischemic preconditioning fails to confer additional protection against ischemia-reperfusion injury in the hypothyroid rat heart. Mourouzis I; Dimopoulos A; Saranteas T; Tsinarakis N; Livadarou E; Spanou D; Kokkinos AD; Xinaris C; Pantos C; Cokkinos DV Physiol Res; 2009; 58(1):29-38. PubMed ID: 18198989 [TBL] [Abstract][Full Text] [Related]
9. Trimetazidine protects isolated rat hearts against ischemia-reperfusion injury in an experimental timing-dependent manner. Pantos C; Bescond-Jacquet A; Tzeis S; Paizis I; Mourouzis I; Moraitis P; Malliopoulou V; Politi ED; Karageorgiou H; Varonos D; Cokkinos DV Basic Res Cardiol; 2005 Mar; 100(2):154-60. PubMed ID: 15616764 [TBL] [Abstract][Full Text] [Related]
10. Role of carvacrol in cardioprotection against myocardial ischemia/reperfusion injury in rats through activation of MAPK/ERK and Akt/eNOS signaling pathways. Chen Y; Ba L; Huang W; Liu Y; Pan H; Mingyao E; Shi P; Wang Y; Li S; Qi H; Sun H; Cao Y Eur J Pharmacol; 2017 Feb; 796():90-100. PubMed ID: 27916558 [TBL] [Abstract][Full Text] [Related]
11. Preventive effect of total flavones of Choerospondias axillaries on ischemia/reperfusion-induced myocardial infarction-related MAPK signaling pathway. Li C; He J; Gao Y; Xing Y; Hou J; Tian J Cardiovasc Toxicol; 2014 Jun; 14(2):145-52. PubMed ID: 24297260 [TBL] [Abstract][Full Text] [Related]
12. A peptide inhibitor of c-Jun NH2-terminal kinase reduces myocardial ischemia-reperfusion injury and infarct size in vivo. Milano G; Morel S; Bonny C; Samaja M; von Segesser LK; Nicod P; Vassalli G Am J Physiol Heart Circ Physiol; 2007 Apr; 292(4):H1828-35. PubMed ID: 17158645 [TBL] [Abstract][Full Text] [Related]
13. Morphine Postconditioning Protects against Reperfusion Injury via Inhibiting JNK/p38 MAPK and Mitochondrial Permeability Transition Pores Signaling Pathways. Chen Z; Zhang X; Liu Y; Liu Z Cell Physiol Biochem; 2016; 39(1):61-70. PubMed ID: 27322569 [TBL] [Abstract][Full Text] [Related]
14. Remifentanil preconditioning confers cardioprotection via c-Jun NH Jin SY; Huang J; Zhu HJ; Wu H; Xu SJ; Irwin MG; He SF; Zhang Y Eur J Pharmacol; 2018 Jun; 828():1-8. PubMed ID: 29559303 [TBL] [Abstract][Full Text] [Related]
15. Ventricular hypertrophy abrogates intralipid-induced cardioprotection by alteration of reperfusion injury salvage kinase/glycogen synthase kinase 3β signal. Ma LL; Ge HW; Kong FJ; Qian LB; Hu BC; Li Q; Xu L; Liu JQ; Xu YX; Sun RH Shock; 2014 May; 41(5):435-42. PubMed ID: 24430545 [TBL] [Abstract][Full Text] [Related]
16. Effect of angiotensin II type 2 receptor blockade on activation of mitogen-activated protein kinases after ischemia-reperfusion in isolated working rat hearts. Kumar D; Menon V; Ford WR; Clanachan AS; Jugdutt BI J Cardiovasc Pharmacol Ther; 2003 Dec; 8(4):285-96. PubMed ID: 14740078 [TBL] [Abstract][Full Text] [Related]
17. Urocortin-2 suppression of p38-MAPK signaling as an additional mechanism for ischemic cardioprotection. Gao XF; Zhou Y; Wang DY; Lew KS; Richards AM; Wang P Mol Cell Biochem; 2015 Jan; 398(1-2):135-46. PubMed ID: 25245818 [TBL] [Abstract][Full Text] [Related]
18. Protective effect of apigenin on ischemia/reperfusion injury of the isolated rat heart. Hu J; Li Z; Xu LT; Sun AJ; Fu XY; Zhang L; Jing LL; Lu AD; Dong YF; Jia ZP Cardiovasc Toxicol; 2015 Jul; 15(3):241-9. PubMed ID: 25377428 [TBL] [Abstract][Full Text] [Related]
20. Postconditioning with Intralipid emulsion protects against reperfusion injury in post-infarct remodeled rat hearts by activation of ROS-Akt/Erk signaling. Zaugg M; Lou PH; Lucchinetti E; Gandhi M; Clanachan AS Transl Res; 2017 Aug; 186():36-51.e2. PubMed ID: 28641075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]